Výsledky vyhledávání - "David Poticha"

Intellectual property-The Foundation of Innovation: A scientist's guide to intellectual property

Publikováno v: Journal of Mass Spectrometry. 54:ii-ii

Increasingly, the activities of the practicing scientist inextricably intersect with the business world. Science is central to the development and delivery of many goods or services, and scientific discovery can directly, or indirectly, lead to subst

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7538f2b657db5d6df62230427dabdf7
https://doi.org/10.1002/jms.4220

Zobrazit plný text záznamu

Inhibition of Purified Recombinant Reverse Transcriptase from Wild‐Type and Zidovudine‐Resistant Clinical Isolates of Human Immunodeficiency Virus Type 1 by Zidovudine, Stavudine, and Lamivudine Triphosphates

Autor: David Poticha, Jeannette M. Whitcomb, Chengying Duan, Daniel R. Kuritzkes, Charles S. McHenry, Christos J. Petropoulos, Thomas C. Stoeckli

Publikováno v: The Journal of Infectious Diseases. 184:1336-1340

Cross-resistance between zidovudine, stavudine, and lamivudine was studied, using purified recombinant reverse transcriptase from a zidovudine-susceptible and -resistant pair of clinical isolates of human immunodeficiency virus type 1. The zidovudine

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0db6f5e5c29568c4473867b53841d7a
https://doi.org/10.1086/323995

Zobrazit plný text záznamu

Emergence of Dual Resistance to Zidovudine and Lamivudine in HIV-1–Infected Patients Treated With Zidovudine Plus Lamivudine as Initial Therapy

Autor: Daniel R. Kuritzkes, Judy Johnson, Mitchell A. Kennedy, David Poticha, David Shugarts, Thomas R. Gingeras, Minoo Bakhtiari, Marc Rubin, Joseph J. Eron

Publikováno v: Scopus-Elsevier

Presence of mutations associated with resistance to zidovudine or lamivudine was determined in isolates of HIV-1 obtained after long-term follow-up of 64 infected individuals who received zidovudine, lamivudine, or both drugs as initial antiretrovira

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0685a248a13e9a7814fdc9e59828bc04
https://doi.org/10.1097/00042560-200001010-00004

Zobrazit plný text záznamu

Drug resistance and virologic response in NUCA 3001, a randomized trial of lamivudine (3TC) versus zidovudine (ZDV) versus ZDV plus 3TC in previously untreated patients

Autor: Minoo Bakhtiari, Mary Ann Fallon, Joseph J. Eron, Aaron Griffin, Daniel R. Kuritzkes, David Poticha, David Shugarts, Joseph B. Quinn, Sharon L. Benoit, Marc Rubin

Publikováno v: AIDS. 10:975-981

Objective: To study the effect of HIV-1 resistance to lamivudine (3TC) and zidovudine (ZDV), and syncytium-inducing (SI) phenotype on virologic response to treatment with ZDV, 3TC, or ZDV plus 3TC in previously untreated individuals with HIV-1 infect

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97c52d5edd8644d49d255919ee498cd7
https://doi.org/10.1097/00002030-199610090-00007

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání